JPMORGAN CHASE & CO - TRANSPHORM INC ownership

TRANSPHORM INC's ticker is TGAN and the CUSIP is 89386L100. A total of 22 filers reported holding TRANSPHORM INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of TRANSPHORM INC
ValueSharesWeighting
Q3 2023$38,901
-90.6%
17,523
-85.6%
0.00%
Q2 2023$414,940
-59.0%
122,041
-51.9%
0.00%
Q1 2023$1,013,000
+1447042.9%
253,839
+1871.1%
0.00%
Q4 2022$70
-99.9%
12,878
+4.4%
0.00%
Q3 2022$62,000
+40.9%
12,334
+7.6%
0.00%
Q2 2022$44,000
-69.9%
11,466
-44.6%
0.00%
Q1 2022$146,00020,7000.00%
Other shareholders
TRANSPHORM INC shareholders Q1 2022
NameSharesValueWeighting ↓
Worth Venture Partners, LLC 609,170$4,307,0001.99%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 374,226$2,646,0001.61%
Kohlberg Kravis Roberts & Co. L.P. 22,175,980$156,784,0001.42%
Foundation Capital, LLC 136,004$962,0000.62%
Soros Fund Management 673,991$4,765,0000.07%
Polar Asset Management Partners Inc. 867,500$6,133,0000.07%
ExodusPoint Capital Management, LP 89,499$633,0000.01%
AMERIPRISE FINANCIAL INC 3,602,481$25,470,0000.01%
Weiss Asset Management LP 43,600$308,0000.01%
Ergoteles LLC 18,900$134,0000.01%
View complete list of TRANSPHORM INC shareholders